The presentation was held at the Mother And Child National Congress on September 29.

The hormone drugs to be manufactured will be used for the following indications:

• contraception,
• hormone replacement therapy for hormone deficiency,
• treatment of gynecologic endocrine disorders.

This line of products is unique in terms of a comprehensive approach to what a woman needs to remain healthy and active at every season of life. A detailed personalization allows considering key peculiarities of each and every woman.

The products will be manufactured at a new Pharmasyntez-Tyumen facility for production of hormonal drugs that is currently one of a kind in Russia.

Hormone drugs of over 30 international nonproprietary names will be manufactured at the facility. Seven manufacturing lines will enable an annual output of about one billion packs. Such a production volume will suffice to substitute up to the half of the Russian market of hormone drugs that are mostly imported from abroad now.

Beware of counterindications. Consult your doctor for more information.